Exane Derivatives’s Procter & Gamble PG Stock Holding History
Bought
Maintained
Sold
Other funds holding PG
Exane Derivatives's PG Position: Q2 2022 in Review
Exane Derivatives reduced its Procter & Gamble (PG) stake by 3.8% in Q2 2022, selling an estimated $21.8K and leaving 3,705 shares worth $533K. The position accounts for 0.31% of the portfolio, ranked #78.
Exane Derivatives first reported a position in PG in Q4 2014 and has held it in 24 quarters since. The position peaked at $5.03M in Q4 2018. 3,254 funds tracked by Wall St. Rank hold PG as of Q2 2022.
- Exane Derivatives held 3,705 shares of Procter & Gamble worth $533K as of Q2 2022.
- Exane Derivatives sold 145 Procter & Gamble shares in Q2 2022, an estimated $21.8K.
- Procter & Gamble made up 0.31% of Exane Derivatives's portfolio in Q2 2022, its #78 holding.
- Exane Derivatives first reported a position in Procter & Gamble in Q4 2014 and has held it in 24 quarters since.
- Exane Derivatives's Procter & Gamble position peaked at $5.03M in Q4 2018.
- 3,254 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.